NP89
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
12/20/2024
Back to search
Official data from USPTO
CELGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELGENE
ST13
US500000076515116Class
1, 5, 40, 41, 42
Filing
76515116
Registration
2888517
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
01/14/2025
Trademark type
Word
Nice classes
1, 5, 40, 41, 42
Filing date
05/19/2003
Registration date
09/28/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/20/2024
Last transaction
01/14/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/31/1986
First use in commerce
12/31/1986
Drawing code
1
Owner type
03
Owner location
Summit, NJ
Examiner
POWERS, ALEXANDER
Holders and representatives
Holders
C. C. (pessoa física)
C. C. (pessoa física)
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 1Class 5Class 40Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
biochemical catalysts for use in medical research; biological preparations for medical purposesfor use in the research of immunologicalinflammatory and neurological disorders; catalysts for use in the manufacture of pharmaceuticals; chemical preparationschemical reagents for scientific purposes; enzyme preparations for industrial purposes; enzymes for industrial purposes; proteins for industrial and human consumptionanimal proteinsgenetic testing reagents for scientific laboratory useDNA probes; chemical preparations used to protect crops in the agricultural and horticultural field; medicinal and biological preparations for medical laboratory usepreparations for the inhibition of gene expression working at DNAtranscriptionRNA or translation processesmodulation of immune system
Class 5
biological preparations for medical purposesnamely for use in the treatment of immunologicalinflammatory and neurological disorders; pharmaceuticalsgenomic and biological agents for use in the fields of immunologicalinflammatory and neurological disorders for the identificationanalysispreventiondetectiondiagnosisprognosis and treatment; biological preparations for use in medicinal testsinoculationstreatment of diseasesimmunologicalinflammatory and neurological disorders and cancer; culture mediatissue culture media and bacteriogical culture media for medical use; medicinal and biological preparations for pharmaceutical and clinical usepreparations for the inhibition of gene expression working at DNAtranscriptionRNA or translation processesmodulation of immune system
Class 40
manufacturing pharmaceutical products for others; custom synthesis of DNA to the order and specification of others; custom manufacturing servicesmanufacturing agrochemicals to the specification of others
Class 41
educational classes and programs in the field of thalidomide and safety issues pertaining to thalidomidedistribution of written materials therewith
Class 42
research in the fields of chemicals and pharmaceuticals; product safety testing in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing servicespharmacogenetic testspredictive medical testspersonalized medical testsgene sequencing-based tests and genotyping base on the assessmentdevelopment and application of genomic discoveries in the pharmaceuticalinformatics and clinical diagnostic industries; providing medical and pharmaceutical research information; scientific research services; design for others in the field of DNA-based assaysDNA sequencing protocolsimmunoassay and methods for drug discovery; scientific researchdevelopment of pharmaceuticals or diagnostic methods for others ; agrochemical product development for others
Publications
History of USPTO decisions and trademark events.
38 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/20/2024
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
12/20/2024
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
12/20/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/20/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/11/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/28/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2022
NOSU
NOTICE OF SUIT
09/10/2020
NOSU
NOTICE OF SUIT
04/20/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/28/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
10/03/2013
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/02/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/02/2013
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
10/02/2013
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
10/02/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/02/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
09/30/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
09/30/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/20/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/20/2009
E815
TEAS SECTION 8 & 15 RECEIVED
10/02/2009
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/16/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
09/28/2004
PUBO
PUBLISHED FOR OPPOSITION
07/06/2004
NPUB
NOTICE OF PUBLICATION
06/16/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2004
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/19/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2003
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2003
CNRT
NON-FINAL ACTION MAILED
12/12/2003
DOCK
ASSIGNED TO EXAMINER
11/29/2003
Continuous trademark protection
Get notified about every new filing that threatens CELGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.